Geoffray Labar

1.1k total citations
20 papers, 924 citations indexed

About

Geoffray Labar is a scholar working on Pharmacology, Surgery and Molecular Biology. According to data from OpenAlex, Geoffray Labar has authored 20 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 9 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Geoffray Labar's work include Cannabis and Cannabinoid Research (15 papers), Pancreatic function and diabetes (9 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Geoffray Labar is often cited by papers focused on Cannabis and Cannabinoid Research (15 papers), Pancreatic function and diabetes (9 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Geoffray Labar collaborates with scholars based in Belgium, France and Sweden. Geoffray Labar's co-authors include Didier M. Lambert, Giulio G. Muccioli, Johan Wouters, Deborah M. Lambert, Catherine Michaux, Cédric Bauvois, Jacques H. Poupaert, Franck Borel, C.J. Fowler and Séverine Vandevoorde and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Geoffray Labar

20 papers receiving 916 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geoffray Labar Belgium 15 571 305 241 214 181 20 924
Cory M. Stiff United States 13 676 1.2× 333 1.1× 121 0.5× 301 1.4× 86 0.5× 17 1.1k
Christophe Hardouin France 16 626 1.1× 444 1.5× 174 0.7× 581 2.7× 117 0.6× 23 1.4k
Lakshmipathi Pandarinathan United States 15 403 0.7× 311 1.0× 91 0.4× 84 0.4× 125 0.7× 22 773
Robert Fecik United States 17 938 1.6× 595 2.0× 137 0.6× 423 2.0× 83 0.5× 27 1.3k
Riku Niemi Finland 13 371 0.6× 173 0.6× 105 0.4× 116 0.5× 88 0.5× 23 702
David K. O’Dell United States 13 285 0.5× 286 0.9× 59 0.2× 134 0.6× 80 0.4× 15 699
Teija Parkkari Finland 17 293 0.5× 351 1.2× 81 0.3× 93 0.4× 52 0.3× 32 666
Katerina Otrubova United States 12 250 0.4× 299 1.0× 59 0.2× 172 0.8× 40 0.2× 15 563
Didier Lambert Belgium 8 252 0.4× 140 0.5× 55 0.2× 88 0.4× 54 0.3× 14 456
Zhaoxing Meng China 12 304 0.5× 147 0.5× 35 0.1× 310 1.4× 39 0.2× 20 705

Countries citing papers authored by Geoffray Labar

Since Specialization
Citations

This map shows the geographic impact of Geoffray Labar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffray Labar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffray Labar more than expected).

Fields of papers citing papers by Geoffray Labar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffray Labar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffray Labar. The network helps show where Geoffray Labar may publish in the future.

Co-authorship network of co-authors of Geoffray Labar

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffray Labar. A scholar is included among the top collaborators of Geoffray Labar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffray Labar. Geoffray Labar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolff, Philippe, Geoffray Labar, Antony Lechner, et al.. (2023). TheBacillus subtilis ywbDgene encodes RlmQ, the 23S rRNA methyltransferase forming m7G2574 in the A-site of the peptidyl transferase center. RNA. 30(2). 105–112. 2 indexed citations
2.
Roovers, Martine, Geoffray Labar, Philippe Wolff, et al.. (2022). The Bacillus subtilis open reading frame ysgA encodes the SPOUT methyltransferase RlmP forming 2′-O-methylguanosine at position 2553 in the A-loop of 23S rRNA. RNA. 28(9). 1185–1196. 7 indexed citations
3.
4.
Caruano, Joséphine, Geoffray Labar, Catherine Michaux, et al.. (2013). (S)-1-(Pent-4′-enoyl)-4-(hydroxymethyl)-azetidin-2-one derivatives as inhibitors of human fatty acid amide hydrolase (hFAAH): synthesis, biological evaluation and molecular modelling. Journal of Enzyme Inhibition and Medicinal Chemistry. 29(5). 654–662. 1 indexed citations
5.
Morera, Ludovica, Geoffray Labar, Giorgio Ortar, & Didier M. Lambert. (2012). Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold. Bioorganic & Medicinal Chemistry. 20(21). 6260–6275. 29 indexed citations
6.
Masquelier, Julien, et al.. (2012). Synthesis and Pharmacological Evaluation of 2,4-Dinitroaryldithiocarbamate Derivatives as Novel Monoacylglycerol Lipase Inhibitors. Journal of Medicinal Chemistry. 55(12). 5774–5783. 65 indexed citations
7.
Labar, Geoffray, et al.. (2011). Benzisothiazolinone as a useful template for the design of new monoacylglycerol lipase inhibitors: Investigation of the target residues and comparison with octhilinone. Bioorganic & Medicinal Chemistry Letters. 21(24). 7321–7324. 9 indexed citations
8.
Wyffels, Leonie, et al.. (2010). PET imaging of fatty acid amide hydrolase in the brain: synthesis and biological evaluation of an 11C-labelled URB597 analogue. Nuclear Medicine and Biology. 37(5). 665–675. 23 indexed citations
9.
Labar, Geoffray, Johan Wouters, & Deborah M. Lambert. (2010). A Review on the Monoacylglycerol Lipase: At the Interface Between Fat and Endocannabinoid Signalling. Current Medicinal Chemistry. 17(24). 2588–2607. 86 indexed citations
10.
Labar, Geoffray, et al.. (2009). Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling. ChemBioChem. 11(2). 218–227. 148 indexed citations
11.
Muccioli, Giulio G., et al.. (2009). Synthesis and in Vitro Evaluation of N-Substituted Maleimide Derivatives as Selective Monoglyceride Lipase Inhibitors. Journal of Medicinal Chemistry. 52(23). 7410–7420. 117 indexed citations
12.
Michaux, Catherine, et al.. (2009). β-Lactams Derived from a Carbapenem Chiron Are Selective Inhibitors of Human Fatty Acid Amide Hydrolase versus Human Monoacylglycerol Lipase. Journal of Medicinal Chemistry. 52(22). 7054–7068. 30 indexed citations
13.
Muccioli, Giulio G., et al.. (2009). Bis(dialkylaminethiocarbonyl)disulfides as Potent and Selective Monoglyceride Lipase Inhibitors. Journal of Medicinal Chemistry. 52(22). 7310–7314. 63 indexed citations
14.
Muccioli, Giulio G., Geoffray Labar, & Didier M. Lambert. (2008). CAY10499, a Novel Monoglyceride Lipase Inhibitor Evidenced by an Expeditious MGL Assay. ChemBioChem. 9(16). 2704–2710. 90 indexed citations
15.
Muccioli, Giulio G., et al.. (2008). Search for monoglyceride lipase inhibitors: synthesis and screening of arylthioamides derivatives. Medicinal Chemistry Research. 18(4). 243–254. 18 indexed citations
16.
Labar, Geoffray, F. Van Vliet, Johan Wouters, & Deborah M. Lambert. (2007). A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison. Amino Acids. 34(1). 127–133. 21 indexed citations
17.
Labar, Geoffray & Catherine Michaux. (2007). Fatty Acid Amide Hydrolase: From Characterization to Therapeutics. Chemistry & Biodiversity. 4(8). 1882–1902. 67 indexed citations
18.
Labar, Geoffray, Cédric Bauvois, Giulio G. Muccioli, Johan Wouters, & Didier M. Lambert. (2007). Disulfiram is an Inhibitor of Human Purified Monoacylglycerol Lipase, the Enzyme Regulating 2‐Arachidonoylglycerol Signaling. ChemBioChem. 8(11). 1293–1297. 51 indexed citations
19.
Vandevoorde, Séverine, et al.. (2006). Lack of selectivity of URB602 for 2‐oleoylglycerol compared to anandamide hydrolysis in vitro. British Journal of Pharmacology. 150(2). 186–191. 77 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cory M. Stiff Breakdown of academic impact, for papers by Christophe Hardouin Breakdown of academic impact, for papers by Lakshmipathi Pandarinathan Breakdown of academic impact, for papers by Robert Fecik Breakdown of academic impact, for papers by Riku Niemi Breakdown of academic impact, for papers by David K. O’Dell Breakdown of academic impact, for papers by Teija Parkkari Breakdown of academic impact, for papers by Katerina Otrubova Breakdown of academic impact, for papers by Didier Lambert Breakdown of academic impact, for papers by Zhaoxing Meng
Rankless by CCL
2026